Scottsdale, AZ · Founded 2017 · Privately Held (backing)
Developer of a medical diagnostic platform designed to detect key pathological markers in the peripheral nervous system. CND Life Sciences is based in Scottsdale, AZ and was founded in 2017. Its last reported valuation was $30.5 million in Mar 2023. It has raised $29.3 million across 7 recorded rounds; the latest was a $4.3 million debt round in Jun 2026.
Last reported valuation
$30.5M
Oct 2026
Priced at
—
Total raised
$29.3M
Last round
Debt
Jun 2026
No prints on record
No secondary trades in CND Life Sciences shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of CND Life Sciences with a free account
·The complete investor list: 14 names
·Watch CND Life Sciences: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of CND Life Sciences stock.
